5 trends in medtech M&A – deal volume up 31.3% in 2018

Written by Laura Dyrda | April 19, 2019 | Print  |

Bain & Company released the Global Healthcare Private Equity and Corporate M&A Report 2019, outlining mergers and acquisitions in several areas of healthcare, including medtech.

Five key trends:

1. In 2018, medtech experienced 67 merger and acquisition deals, totaling $10.5 billion. Last year's deals were up significantly from 2017, when there were 51 deals totaling $6.5 billion. The deal volume in Europe drove overall volume growth in 2018.

2. There were five deals in 2018 that totaled more than $1 billion, compared with one similar deal in 2017. Deals in North America and Asia-Pacific were responsible for the increase in value over the past year.

3. Prices are increasing in part due to competition from buyout firms and corporate acquirers. Three deals last year that were public-to-private transactions were in the top 10 deals worldwide.

4. Headwinds in the industry, like pricing pressure from providers and provider consolidation, present challenges in the field, and in some cases force medtech to lower general and administrative spending and inventory, according to the report.

5. Private equity will look for investment opportunities in medtech as the companies "hone their product development and manufacturing," such as Nordic Capital's 2019 investment in Orchid Orthopedic Solutions. "We expect to see a continued push into services as firms look for attractive consolidation opportunities," states the report.

More articles on orthopedic devices:
Orthopedic imaging in 2019 – Key thoughts from EOS imaging CEO Mike Lobinsky
NuVasive introduces new spine surgery technology & more: 5 device company notes
Stryker brings SpineMap Go software to market: 3 quick points

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months